Lundin J - Search Results

1

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Joensuu H, Isola J, Lundin M, Salminen T, Holli K, Kataja V, Pylkkänen L, Turpeenniemi-Hujanen T, von Smitten K, Lundin J. Joensuu H, et al. Among authors: lundin j, lundin m. Clin Cancer Res. 2003 Mar;9(3):923-30. Clin Cancer Res. 2003. PMID: 12631589

2

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer.

Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C. Lundin J, et al. Oncology. 1996 Mar-Apr;53(2):104-11. doi: 10.1159/000227545. Oncology. 1996. PMID: 8604235

3

Expression of p53 protein as a prognostic factor in patients with gastric cancer.

Victorzon M, Nordling S, Haglund C, Lundin J, Roberts PJ. Victorzon M, et al. Among authors: lundin j. Eur J Cancer. 1996 Feb;32A(2):215-20. doi: 10.1016/0959-8049(95)00547-1. Eur J Cancer. 1996. PMID: 8664030

4

A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy--a multivariate analysis.

Victorzon M, Lundin J, Haglund C, Nordling S, Roberts PJ. Victorzon M, et al. Among authors: lundin j. Int J Cancer. 1996 Jul 17;67(2):190-3. doi: 10.1002/(SICI)1097-0215(19960717)67:2<190::AID-IJC7>3.0.CO;2-O. Int J Cancer. 1996. PMID: 8760586

5

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer.

Railo M, Lundin J, Haglund C, von Smitten K, von Boguslawsky K, Nordling S. Railo M, et al. Among authors: lundin j. Acta Oncol. 1997;36(4):369-74. doi: 10.3109/02841869709001282. Acta Oncol. 1997. PMID: 9247096

6

Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis.

Lundin M, Nordling S, Roberts PJ, Lundin J, Carpelan-Holmström M, von Boguslawsky K, Haglund C. Lundin M, et al. Among authors: lundin j. Oncology. 1999 Jul;57(1):70-6. doi: 10.1159/000012003. Oncology. 1999. PMID: 10394128

7

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C. Poikonen P, et al. Among authors: lundin j. Br J Cancer. 1999 Aug;80(11):1763-6. doi: 10.1038/sj.bjc.6690594. Br J Cancer. 1999. PMID: 10468293 Free PMC article. Clinical Trial.

8

Artificial neural networks applied to survival prediction in breast cancer.

Lundin M, Lundin J, Burke HB, Toikkanen S, Pylkkänen L, Joensuu H. Lundin M, et al. Among authors: lundin j. Oncology. 1999 Nov;57(4):281-6. doi: 10.1159/000012061. Oncology. 1999. PMID: 10575312

9

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study.

Lundin J, Lundin M, Holli K, Kataja V, Elomaa L, Pylkkänen L, Turpeenniemi-Hujanen T, Joensuu H. Lundin J, et al. Among authors: lundin m. J Clin Oncol. 2001 Jan 1;19(1):28-36. doi: 10.1200/JCO.2001.19.1.28. J Clin Oncol. 2001. PMID: 11134192

10

Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer.

Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, von Boguslawski K, Haglund C. Wiksten JP, et al. Among authors: lundin j, lundin m. Int J Cancer. 2001 Jan 20;95(1):1-6. doi: 10.1002/1097-0215(20010120)95:1<1::aid-ijc1000>3.0.co;2-5. Int J Cancer. 2001. PMID: 11241302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters